Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Global Antimicrobial Resistance|July 18, 2021
In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014-2018 studies in SpainEmilia Cercenado, Laura Cardenoso, Rocio Penin, et al.Journal of Global Antimicrobial Resistance|December 17, 2021
In vitro activity of cefiderocol against Gram-negative bacterial pathogens in GermanyPhilipp Thelen, Anne Santerre Henriksen, Christopher Longshaw, et al.Antibiotics (Basel, Switzerland)|February 25, 2022
Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical IsolatesClara Ballesté-Delpierre, Ángel Ramírez, Laura Muñoz, et al.The Journal of Antimicrobial Chemotherapy|April 6, 2021
Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance ProgrammeCarolyne Horner, Shazad Mushtaq, Michael Allen, et al.The Journal of Antimicrobial Chemotherapy|February 13, 2023
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumanniiChristian M Gill, Debora Santini, Miki Takemura, et al.Antibiotics (Basel, Switzerland)|October 27, 2022
In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and BelgiumSaoussen Oueslati, Pierre Bogaerts, Laurent Dortet, et al.Infectious Disease Reports|September 11, 2020
Insights into the Clinical Management of Carbapenem-Resistant Gram-Negative Infections: An Italian Retrospective Clinical Chart ReviewGuido Granata, Davide Manissero, Maria Vittoria Oppia, et al.The Journal of Antimicrobial Chemotherapy|October 27, 2025
Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and futureBenjamin J Parcell, Carolyne Horner, Rosy Reynolds, et al.Microbiology Spectrum|June 21, 2024
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinationsAnne Santerre Henriksen, Fabio Arena, Marie Attwood, et al.Jac-Antimicrobial Resistance|December 15, 2021
Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemiasCarolyne Horner, Shazad Mushtaq, Michael Allen, et al.Pageof 4